Concepts (123)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Acne Vulgaris | 6 | 2014 | 102 | 0.600 |
Why?
|
| Dermatologic Agents | 6 | 2015 | 235 | 0.580 |
Why?
|
| Hemangioma | 1 | 2019 | 24 | 0.580 |
Why?
|
| Methotrexate | 3 | 2014 | 71 | 0.570 |
Why?
|
| Disease Management | 1 | 2019 | 134 | 0.540 |
Why?
|
| Skin Neoplasms | 2 | 2019 | 225 | 0.530 |
Why?
|
| Practice Guidelines as Topic | 2 | 2019 | 431 | 0.520 |
Why?
|
| Scleroderma, Localized | 1 | 2013 | 6 | 0.400 |
Why?
|
| Pityriasis Lichenoides | 1 | 2011 | 4 | 0.360 |
Why?
|
| Stevens-Johnson Syndrome | 1 | 2011 | 9 | 0.360 |
Why?
|
| Skin Ulcer | 1 | 2011 | 12 | 0.360 |
Why?
|
| Herpes Simplex | 1 | 2011 | 14 | 0.360 |
Why?
|
| Adolescent Development | 1 | 2010 | 3 | 0.330 |
Why?
|
| Anti-Bacterial Agents | 5 | 2012 | 352 | 0.250 |
Why?
|
| Infant | 5 | 2019 | 1123 | 0.240 |
Why?
|
| Child | 12 | 2015 | 2614 | 0.210 |
Why?
|
| Immunosuppressive Agents | 2 | 2015 | 251 | 0.190 |
Why?
|
| Adolescent | 8 | 2014 | 3805 | 0.190 |
Why?
|
| Prednisone | 2 | 2013 | 70 | 0.190 |
Why?
|
| Child, Preschool | 8 | 2015 | 1355 | 0.180 |
Why?
|
| Humans | 19 | 2019 | 34562 | 0.170 |
Why?
|
| Retinoids | 2 | 2014 | 43 | 0.160 |
Why?
|
| Combined Modality Therapy | 3 | 2019 | 590 | 0.150 |
Why?
|
| Medication Adherence | 2 | 2010 | 163 | 0.140 |
Why?
|
| Female | 12 | 2015 | 21532 | 0.130 |
Why?
|
| Lichen Sclerosus et Atrophicus | 1 | 2015 | 10 | 0.110 |
Why?
|
| Clobetasol | 1 | 2015 | 27 | 0.110 |
Why?
|
| Tacrolimus | 1 | 2015 | 68 | 0.110 |
Why?
|
| Drug Therapy, Combination | 2 | 2014 | 318 | 0.110 |
Why?
|
| Off-Label Use | 1 | 2014 | 15 | 0.110 |
Why?
|
| Prescriptions | 1 | 2014 | 15 | 0.110 |
Why?
|
| Anti-Infective Agents | 1 | 2014 | 46 | 0.100 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2014 | 46 | 0.100 |
Why?
|
| Remission Induction | 1 | 2013 | 97 | 0.100 |
Why?
|
| Male | 10 | 2014 | 20740 | 0.100 |
Why?
|
| Retrospective Studies | 4 | 2015 | 3825 | 0.100 |
Why?
|
| Rocky Mountain Spotted Fever | 1 | 2013 | 9 | 0.100 |
Why?
|
| Intracranial Hypertension | 1 | 2013 | 21 | 0.100 |
Why?
|
| Exanthema | 1 | 2013 | 20 | 0.100 |
Why?
|
| Health Care Surveys | 4 | 2014 | 191 | 0.100 |
Why?
|
| Impetigo | 1 | 2012 | 5 | 0.090 |
Why?
|
| Young Adult | 3 | 2014 | 2831 | 0.090 |
Why?
|
| Puberty, Precocious | 1 | 2011 | 2 | 0.090 |
Why?
|
| Clindamycin | 1 | 2011 | 23 | 0.090 |
Why?
|
| Vancomycin | 1 | 2011 | 24 | 0.090 |
Why?
|
| Treatment Outcome | 4 | 2011 | 3623 | 0.080 |
Why?
|
| Eczema | 1 | 2010 | 14 | 0.080 |
Why?
|
| Adult | 5 | 2014 | 10030 | 0.080 |
Why?
|
| Follow-Up Studies | 2 | 2013 | 2367 | 0.080 |
Why?
|
| Patient Care Planning | 1 | 2010 | 58 | 0.070 |
Why?
|
| Attitude of Health Personnel | 1 | 2010 | 193 | 0.070 |
Why?
|
| Dermatitis, Atopic | 1 | 2010 | 103 | 0.070 |
Why?
|
| Pediatrics | 1 | 2010 | 167 | 0.070 |
Why?
|
| Time Factors | 1 | 2013 | 2353 | 0.070 |
Why?
|
| Granuloma, Pyogenic | 1 | 2006 | 5 | 0.060 |
Why?
|
| Aminoquinolines | 1 | 2006 | 18 | 0.060 |
Why?
|
| Sunlight | 1 | 2005 | 18 | 0.060 |
Why?
|
| United States | 5 | 2014 | 4278 | 0.060 |
Why?
|
| Erythromycin | 1 | 2005 | 8 | 0.060 |
Why?
|
| Ultraviolet Rays | 1 | 2005 | 52 | 0.060 |
Why?
|
| Tetracycline | 1 | 2005 | 14 | 0.060 |
Why?
|
| Isotretinoin | 1 | 2005 | 13 | 0.060 |
Why?
|
| Benzoyl Peroxide | 1 | 2005 | 20 | 0.060 |
Why?
|
| Child Health Services | 1 | 2005 | 26 | 0.060 |
Why?
|
| Respiratory Tract Diseases | 1 | 2005 | 39 | 0.060 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2005 | 38 | 0.060 |
Why?
|
| Urban Population | 1 | 2005 | 97 | 0.050 |
Why?
|
| Complementary Therapies | 1 | 2005 | 80 | 0.050 |
Why?
|
| Quality of Life | 1 | 2010 | 1032 | 0.050 |
Why?
|
| Melanoma | 1 | 2005 | 170 | 0.050 |
Why?
|
| Skin Diseases | 1 | 2006 | 149 | 0.050 |
Why?
|
| Diagnosis, Differential | 1 | 2005 | 542 | 0.050 |
Why?
|
| Patient Education as Topic | 1 | 2005 | 261 | 0.050 |
Why?
|
| Rural Population | 1 | 2005 | 297 | 0.050 |
Why?
|
| Tonsillitis | 1 | 2003 | 7 | 0.050 |
Why?
|
| Risk Assessment | 4 | 2014 | 1508 | 0.050 |
Why?
|
| Staphylococcal Infections | 1 | 2003 | 83 | 0.050 |
Why?
|
| Antineoplastic Agents | 1 | 2006 | 628 | 0.040 |
Why?
|
| Administration, Topical | 2 | 2014 | 146 | 0.040 |
Why?
|
| Recurrence | 3 | 2007 | 296 | 0.040 |
Why?
|
| Chronic Disease | 2 | 2015 | 439 | 0.040 |
Why?
|
| Administration, Cutaneous | 2 | 2012 | 119 | 0.040 |
Why?
|
| Psoriasis | 1 | 2003 | 362 | 0.030 |
Why?
|
| Middle Aged | 4 | 2014 | 12726 | 0.030 |
Why?
|
| Leukemia, Lymphoid | 1 | 2014 | 4 | 0.030 |
Why?
|
| Pancytopenia | 1 | 2014 | 5 | 0.030 |
Why?
|
| Drug Interactions | 1 | 2014 | 90 | 0.030 |
Why?
|
| Drug Monitoring | 1 | 2014 | 30 | 0.030 |
Why?
|
| Glucocorticoids | 1 | 2015 | 154 | 0.030 |
Why?
|
| Medicaid | 1 | 2014 | 105 | 0.020 |
Why?
|
| Ambulatory Care | 1 | 2014 | 113 | 0.020 |
Why?
|
| Rickettsia rickettsii | 1 | 2013 | 4 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2013 | 88 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2013 | 136 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2014 | 755 | 0.020 |
Why?
|
| Prognosis | 2 | 2007 | 1606 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2014 | 730 | 0.020 |
Why?
|
| Severity of Illness Index | 2 | 2007 | 922 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2012 | 213 | 0.020 |
Why?
|
| Age of Onset | 1 | 2011 | 95 | 0.020 |
Why?
|
| African Continental Ancestry Group | 1 | 2011 | 367 | 0.020 |
Why?
|
| Dermatology | 1 | 2012 | 164 | 0.020 |
Why?
|
| Aged | 2 | 2014 | 11022 | 0.020 |
Why?
|
| Sex Factors | 1 | 2011 | 708 | 0.020 |
Why?
|
| Prevalence | 1 | 2011 | 1034 | 0.020 |
Why?
|
| European Continental Ancestry Group | 1 | 2011 | 1176 | 0.020 |
Why?
|
| Biopsy, Needle | 1 | 2007 | 100 | 0.020 |
Why?
|
| Risk Factors | 1 | 2014 | 4137 | 0.010 |
Why?
|
| Sunburn | 1 | 2005 | 3 | 0.010 |
Why?
|
| Carcinoma, Basal Cell | 1 | 2005 | 27 | 0.010 |
Why?
|
| Skin Pigmentation | 1 | 2005 | 27 | 0.010 |
Why?
|
| Evidence-Based Medicine | 1 | 2007 | 230 | 0.010 |
Why?
|
| Fingers | 1 | 2006 | 78 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2007 | 600 | 0.010 |
Why?
|
| Disease Progression | 1 | 2007 | 634 | 0.010 |
Why?
|
| Acute Disease | 1 | 2005 | 277 | 0.010 |
Why?
|
| Diet | 1 | 2007 | 418 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2012 | 4157 | 0.010 |
Why?
|
| Survival Rate | 1 | 2005 | 928 | 0.010 |
Why?
|
| Tonsillectomy | 1 | 2003 | 12 | 0.010 |
Why?
|
| Age Factors | 1 | 2005 | 1262 | 0.010 |
Why?
|
| Incidence | 1 | 2005 | 1290 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2003 | 565 | 0.010 |
Why?
|